Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
Home
Authors
Posts by Andrew M.
Andrew M.
110 POSTS
0 COMMENTS
Biotech News
Therma Bright Provides Corporate Update on the Saringer and Orpheus Transactions
Therma Bright Inc.
-
August 20, 2020
0
Biotech Insights
China Biologic Products Falls Short of Q2 Expectations as COVID-19 Weighs
Andrew M.
-
August 20, 2020
0
Biotech News
BetterLife Announces Closing of Private Placement
BetterLife Pharma Inc.
-
August 19, 2020
0
Biotech News
Avivagen Announces Publication of Scientific Paper in British Journal of Nutrition
Avivagen Inc.
-
August 18, 2020
0
1
2
3
...
28
Page 1 of 28
- Advertisement -
LATEST NEWS
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Avivagen Inc.
-
December 22, 2020
Therma Bright Achieves High Accuracy Results from Feasibility Studies for Its COVID-19 Rapid Saliva...
Avivagen Inc.
-
December 8, 2020
Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.
Avivagen Inc.
-
October 20, 2020
Cardiol Therapeutics Receives FDA Approval For Investigational New Drug (IND) Application For Phase II/III...
Avivagen Inc.
-
September 25, 2020
LATEST INTERVIEWS
Edit with Live CSS
